Company / Cash per Share
Astria Therapeutics, Inc. Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.07
FY2024
5-year range
$1.07 / $9.69
FY2020-FY2024
Trend
-81.7%
vs FY2023
Sector context
#145 of 205
Health Care
What the data says
At $1.07, Astria Therapeutics, Inc.'s cash per share ranks #145 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $1.02 in FY2019 to $9.69 in FY2021.
Based on SEC 10-K filings.
1.07 in FY2024 with a 5-year CAGR of +0.8%.
Declined from $1.40 to $1.07 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -52.1%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
#145 of 205 in Health CareTop 71% of 205This company $1.07 Sector average $72.93
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2024, cash per share decreased 81.7% year-over-year.
- Ranks #145 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.07 | -81.7% |
| FY2023 | $5.83 | +315.1% |
| FY2022 | $1.40 | -85.5% |
| FY2021 | $9.69 | +18.9% |
| FY2020 | $8.15 | +697.6% |
| FY2019 | $1.02 | -66.2% |
| FY2018 | $3.03 | -59.9% |
| FY2017 | $7.55 | +419.3% |
| FY2016 | $1.45 | -81.4% |
| FY2015 | $7.81 | -77.4% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026